Market Place
Sourcing Support
Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders
10 Feb 2021 //
BIOSPACE
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement
10 Dec 2020 //
GLOBENEWSWIRE
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement,
10 Dec 2020 //
GLOBENEWSWIRE
Neos Therapeutics Announces Issuance of New U.S. N-desethyloxybutynin
09 Apr 2020 //
MARKETWATCH
Neos Therapeutics Initiates and Completes Dosing in a Phase 1 Trial of NT0502
13 Jan 2020 //
GLOBENEWSWIRE
Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea
29 Oct 2018 //
BIOSPACE
Andrew Ritter gathers the reins PhIII; Solid Bio co-founder Gilad Hayeem retires
29 Jun 2018 //
ENDPTS
8 Biotech Companies with Upcoming Catalysts
14 Mar 2018 //
BIOSPACE
Neos`s Reiterates Confidence in Strategic Plan and Value Creation Opportunities
20 Feb 2018 //
PR NEWSWIRE
Neos Therapeutics Seems To Be Capitalizing On Pfizer`s Decisions
15 Jan 2018 //
SEEKINGALPHA
Neos considering offers after rejecting PDL’s $300M bid: Reuters
31 Oct 2017 //
ENDPTS
Neos Therapeutics to consider other offers after PDL snub: sources
31 Oct 2017 //
REUTERS
PDL BioPharma Issues Statement in Response to Neos Therapeutics Rejection
30 Oct 2017 //
PR NEWSWIRE
PDL goes public with hostile bid to buy Neos
27 Oct 2017 //
FIERCE BIOTECH
PDL gets aggressive with an offer to buy out Neos Therapeutics
26 Oct 2017 //
ENDPTS
Reports on Generic Drugs Stocks Adamas, Eagle Pharma, Neos & Zynerba Pharma
22 Sep 2017 //
PR NEWSWIRE
Neos Therapeutics shares fall after FDA approves new formulation of ADHD drug
15 Sep 2017 //
MARKETWATCH
Generic Drugs Stock Performance Review- Pacira, Eagle Pharma, Neos & Zynerba
11 Aug 2017 //
PR NEWSWIRE
Neos, facing critics, snags another pediatric ADHD nod
21 Jun 2017 //
FIERCE PHARMA
Neos Therapeutics Resubmits ADHD Drug Marketing Application
21 Dec 2016 //
REUTERS
Neos Submits NDA for Amphetamine Extended-Release Liquid Suspension Drug
17 Nov 2016 //
GLOBENEWEWIRE
Neos Therapeutics (NEOS) Closes $60 Million Term Debt Financing Deal
16 May 2016 //
BIOSPACE
FDA approves Neos Therapeutics` long-acting ADHD drug
27 Jan 2016 //
REUTERS
Neos pulls off a $72M IPO to push its ADHD drugs forward
24 Jul 2015 //
FIERCE BIOTECH
Neos angles for a $74M IPO to fund its ADHD drugs
13 Jul 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.